Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Werewolf Therapeutics (HOWL) Other Non Operating Income (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Other Non Operating Income for 5 consecutive years, with $179000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Non Operating Income changed N/A to $179000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $2.3 million, a 234.65% increase, with the full-year FY2024 number at $1.6 million, up 241.42% from a year prior.
  • Other Non Operating Income was $179000.0 for Q3 2025 at Werewolf Therapeutics, up from -$168000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.2 million in Q4 2024 to a low of -$1.1 million in Q4 2023.
  • A 5-year average of -$14294.1 and a median of -$16000.0 in 2021 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: plummeted 6812.5% in 2023, then soared 16900.0% in 2025.
  • Werewolf Therapeutics' Other Non Operating Income stood at -$17000.0 in 2021, then surged by 511.76% to $70000.0 in 2022, then crashed by 1731.43% to -$1.1 million in 2023, then surged by 289.84% to $2.2 million in 2024, then tumbled by 91.74% to $179000.0 in 2025.
  • Per Business Quant, the three most recent readings for HOWL's Other Non Operating Income are $179000.0 (Q3 2025), -$168000.0 (Q2 2025), and $168000.0 (Q1 2025).